Status:

RECRUITING

Transcutaneous Auricular Neurostimulation After Lumbar Surgery

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Pain, Postoperative

Opioid Use

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The purpose of this study, entitled "Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery", is to demonstrate wh...

Detailed Description

This study is designed as a randomized, double-blind, sham-controlled, single-center, clinical trial in which 20 patients undergoing lumbar spine surgery will be randomized 1:1 into one of two treatme...

Eligibility Criteria

Inclusion

  • Medically cleared to undergo a lumbar spine surgery, either spinal fusion with or without multilevel laminectomies, or lumbar multilevel laminectomies alone.
  • 18-85 years of age
  • English Proficiency
  • Participants must be able to provide informed consent and function at an intellectual level sufficient for study requirements

Exclusion

  • Current evidence of an uncontrolled and/or clinically significant medical condition
  • History of bleeding disorders or coagulopathy
  • History of seizures or epilepsy
  • History of neurological diseases or traumatic brain injury
  • Use of illegal recreational drugs
  • Presence of devices, e.g. pacemakers, cochlear prosthesis, neuro-stimulators
  • Use of acupuncture within 4 weeks of surgery
  • Grossly abnormal external ear anatomy or active ear infection
  • Women of childbearing potential, not using effective contraception per investigator judgment or not willing to comply with contraception for the duration of the study
  • Females who are pregnant or lactating
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial

Key Trial Info

Start Date :

October 29 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06100172

Start Date

October 29 2024

End Date

December 1 2027

Last Update

December 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT Southwestern Medical Center

Dallas, Texas, United States, 75390